Neuroleptic Dose in the Management of Delirium in Patients with Advanced Cancer

Journal of Pain and Symptom Management

Volumn 39, Issue 2, 2010, Pages 186-196

  Hui, David ^a   Bush, Shirley H ^a,b,c   Gallo, Laura E ^a   Palmer, J Lynn ^a   Yennurajalingam, Sriram ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Southern Healthcare Network   (Australia)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Delirium; haloperidol; neoplasms; neuroleptic agents; palliative care

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; LORAZEPAM; MIDAZOLAM; NEUROLEPTIC AGENT; OLANZAPINE;

ADD ON THERAPY; ADULT; ADVANCED CANCER; AGED; AGITATION; ARTICLE; CANCER PATIENT; CAREGIVER; CORRELATION ANALYSIS; CORRELATIONAL STUDY; DELIRIUM; DISTRESS SYNDROME; DRUG EFFICACY; DRUG USE; FEMALE; HEALTH CARE PERSONNEL; HUMAN; JOB STRESS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL SPECIALIST; NURSE; PALLIATIVE THERAPY; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SYMPTOM;

ADULT; AFFECTIVE SYMPTOMS; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIPSYCHOTIC AGENTS; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HALOPERIDOL; HUMANS; MALE; MENTAL RECALL; MIDDLE AGED; NEOPLASMS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES;

EID: 75749120617     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2009.07.009     Document Type: Article

References (34)

1. Breitbart W., and Strout D. Delirium in the terminally ill. Clin Geriatr Med 16 (2000) 357-372
2. Centeno C., Sanz A., and Bruera E. Delirium in advanced cancer patients. Palliat Med 18 (2004) 184-194
3. Lawlor P.G., and Bruera E.D. Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 16 (2002) 701-714
4. Lawlor P.G., Gagnon B., Mancini I.L., et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160 (2000) 786-794
5. Breitbart W., Bruera E., Chochinov H., and Lynch M. Neuropsychiatric syndromes and psychological symptoms in patients with advanced cancer. J Pain Symptom Manage 10 (1995) 131-141
6. Bruera E., Miller L., McCallion J., et al. Cognitive failure in patients with terminal cancer: a prospective study. J Pain Symptom Manage 7 (1992) 192-195
7. Gagnon B., Lawlor P.G., Mancini I.L., et al. The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patients. J Pain Symptom Manage 22 (2001) 826-833
8. Francis J., and Kapoor W.N. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc 40 (1992) 601-606
9. Attard A., Ranjith G., and Taylor D. Delirium and its treatment. CNS Drugs 22 (2008) 631-644
10. Fang C.K., Chen H.W., Liu S.I., et al. Prevalence, detection and treatment of delirium in terminal cancer inpatients: a prospective survey. Jpn J Clin Oncol 38 (2008) 56-63
11. Lonergan E., Britton A.M., and Luxenberg J. Antipsychotics for delirium. CD005594. Cochrane Database Syst Rev 2 (2007) 10.1002/14651858.CD005594.pub2
12. Lacasse H., Perreault M.M., and Williamson D.R. Systematic review of antipsychotics for the treatment of hospital-associated delirium in medically or surgically ill patients. Ann Pharmacother 40 (2006) 1966-1973
13. Inouye S.K. Delirium in older persons. N Engl J Med 354 (2006) 1157-1165
14. Akechi T., Uchitomi Y., Okamura H., et al. Usage of haloperidol for delirium in cancer patients. Support Care Cancer 4 (1996) 390-392
15. Olofsson S.M., Weitzner M.A., Valentine A.D., Baile W.F., and Meyers C.A. A retrospective study of the psychiatric management and outcome of delirium in the cancer patient. Support Care Cancer 4 (1996) 351-357
16. Breitbart W., Chochinov H.M., and Passik S.D. Psychiatric symptoms in palliative medicine. In: Doyle D., Hanks G., Cherny N.I., and Calman K. (Eds). Oxford textbook of palliative medicine. 3rd ed. (2004), Oxford University Press, New York 746-771
17. Bruera E., Bush S.H., Willey J., et al. The impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers. Cancer 9 (2009) 2004-2012
18. Breitbart W., Rosenfeld B., Roth A., et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 13 (1997) 128-137
19. Rijcken C.A., Monster T.B., Brouwers J.R., and de Jong-van den Berg L.T. Chlorpromazine equivalents versus defined daily doses: how to compare antipsychotic drug doses?. J Clin Psychopharmacol 23 (2003) 657-659
20. WHO Collaborating Centre for Drug Statistics Methodology. Available from:. http://www.whocc.no/atcddd/ Accessed November 12, 2008
21. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
22. Breitbart W., Gibson C., and Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics 43 (2002) 183-194
23. Breitbart W., Marotta R., Platt M.M., et al. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatry 153 (1996) 231-237
24. Han C.S., and Kim Y.K. A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics 45 (2004) 297-301
25. Skrobik Y.K., Bergeron N., Dumont M., and Gottfried S.B. Olanzapine vs. haloperidol: treating delirium in a critical care setting. Intensive Care Med 30 (2004) 444-449
26. Casarett D.J., Inouye S.K., and American College of Physicians-American Society of Internal Medicine End-of-Life Care Consensus Panel. Diagnosis and management of delirium near the end of life. Ann Intern Med 135 (2001) 32-40
27. Riker R.R., Fraser G.L., and Cox P.M. Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 22 (1994) 433-440
28. Nakamura J., Uchimura N., Yamada S., and Nakazawa Y. Does plasma free-3-methoxy-4-hydroxyphenyl(ethylene)glycol increase in the delirious state? A comparison of the effects of mianserin and haloperidol on delirium. Int Clin Psychopharmacol 12 (1997) 147-152
29. Sipahimalani A., and Masand P.S. Olanzapine in the treatment of delirium. Psychosomatics 39 (1998) 422-430
30. Schwartz T.L., and Masand P.S. Treatment of delirium with quetiapine. Prim Care Companion J Clin Psychiatry 2 (2000) 10-12
31. Hu H., Deng W., and Yang H. A prospective random control study comparison of olanzapine and haloperidol in senile delirium. Chongging Med J 8 (2004) 1234-1237
32. Kim J.Y., Jung I.K., Han C., et al. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 59 (2005) 183-188
33. Cohen I.L. Management of the agitated intensive care unit patient. Crit Care Med 30 1 Suppl A (2002) S97-S123
34. Vella-Brincat J., and Macleod A.D. Haloperidol in palliative care. Palliat Med 18 (2004) 195-201